Nirmalya Roy Moulik, MD, PhD, MRCPCH, Tata Memorial Centre, Mumbai, India, outlines some of the obstacles associated with managing children with chronic myeloid leukemia (CML) in a resource-constrained country, including limited tyrosine kinase inhibitor (TKI) and transplant availability. This interview took place at the 24th Annual John Goldman Conference on Chronic Myeloid Leukemia (ESH CML) held in Mandelieu-La Napoule, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.